Answers are grounded in this paper and cite their sources.
Plasma neurofilament light chain (NfL) has been reported to increase following acute and repeated exposure to altitude. Independently, optic nerve sheath diameter (ONSD) has been shown to increase at altitude. In this study, we measured NfL and ONSD in parallel before, during and after a 44‐h sojourn at 3100 m, and examined whether these changes were associated. Twelve healthy adults of either sex were transported to 3100 m. Blood samples and sonographic assessment of the ONSD were obtained at baseline and after 24 and 44 h at altitude. Plasma analyses included NfL and glial fibrillary acidic protein (GFAP). The occurrence of acute mountain sickness (AMS) was assessed using the Lake Louise Score. Over 44 h, the age‐ and body mass index‐standardized z ‐score of NfL increased from 0.88 to 1.17 (median, P = 0.050). Concurrently, ONSD increased from 4.30 mm to 4.80 mm (median, P = 0.016). Linear regression analysis showed that z ‐score of NfL, as the dependent variable, was not associated with ONSD, the independent variable ( R 2 = 0.026, P = 0.354). Mixed model linear regression revealed an association but with a small effect size. GFAP, as a marker of blood–brain barrier injury and inflammatory parameters, remained unaffected by exposure to altitude. No participant developed AMS. An altitude of 3100 m is attainable by many individuals, but is associated with reduced oxygen availability and a risk of AMS. At this altitude in our experiment, plasma NfL and ONSD increased in parallel but with little to no association over 44 h.
No takes yet. Share an insight, caveat, or question.
Treml et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: